Activity Description:

This Tumor Board series is a specialized case-based educational forum designed to bring together a multidisciplinary team of healthcare professionals—including oncologists, radiologists, pathologists, surgeons, and other specialists—to collaboratively discuss complex tumor cases. Each session involves in-depth presentations of real patient cases, highlighting critical diagnostic, therapeutic, and management challenges. This collaborative approach allows participants to engage in a dynamic roundtable discussion, where they can pose questions, share expertise, and explore a variety of treatment pathways. By analyzing each patient's unique medical context, healthcare providers enhance their clinical knowledge and improve decision-making strategies, ultimately aiming to advance patient outcomes through well-informed, team-based care solutions.

Target Audience:

This course is designed for Anesthesiology, Diagnostic Radiology, Internal Medicine, Medical Genetics, Pathology, Physical Medicine & Rehabilitation, Surgery, Urology.

Learning Objectives:

• Utilize multidisciplinary approaches to diagnosis and staging of patients with cancer to identify unusual clinical and/or challenging situations.
• Describe methodologies of practice that would promote better clinical understanding for the treatment of these unusual clinical situations.
• Analyze patient's unique medical context, including cultural, linguistic, ethnic, religious, and socio-economic barriers which may affect a patient's treatment.

Moderator:

Moshen Arani, MD

Anna Belcheva, MD

Lori Wilson, Director, Physician and Provider Relations

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare Gulf Coast Division. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.